References
- Åberg F, Färkkilä M, Männistö V. Interaction between alcohol use and metabolic risk factors for liver disease: a critical review of epidemiological studies. Alcohol Clin Exp Res. 2020;44(2):384–403.
- Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of non-alcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.
- Cusi K, Isaacs S, Barb D, et al. Endocrine practice American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings Co-Sponsored by the American association. Endocr Pract. 2022;28(5):528–562.
- Ando Y, Jou JH. Nonalcoholic fatty liver disease and recent guideline updates. Clin Liver Dis. 2021;17(1):23–28.
- Tsochatzis E, Coilly A, Nadalin S, et al. International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation. Transplantation. 2019;103(1):45–56.
- Monelli F, Venturelli F, Bonilauri L, et al. Systematic review of existing guidelines for NAFLD assessment. Hepatoma Res. 2021;7:25. http://dx.doi.org/10.20517/2394-5079.2021.03
- Kanwal F, Shubrook JH, Adams LA, et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161(5):1657–1669.
- EASL-EASD-EASO Clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–1402.
- Wani Z, Bhat R, Bhadoria A, et al. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification. Saudi J Gastroenterol. 2015; May 121(3):129–138.
- Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and Meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739–752.
- Conus F, Rabasa-Lhoret R, Péronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab. 2007;32(1):4–12.
- Younes R, Bugianesi E. NASH in lean individuals. Semin Liver Dis. 2019;39(1):86–95.
- Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis 2020. J Gastroenterol. 2021;56(11):951–963.
- Gastaldelli A, Sabatini S, Carli F, et al. PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. Liver Int. 2021;41(11):2659–2670.
- Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of non-alcoholic steatohepatitis. Gastroenterology [Internet]. 2015;149(2):367–378.e5.
- Francque SM, Marchesini G, Kautz A, et al. Non-alcoholic fatty liver disease: a patient guideline. JHEP Rep. 2021;3(5):100322.
- Musso G, Cassader M, Rosina F, et al. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and Meta-analysis of randomised trials. Diabetologia. 2012;55(4):885–904.
- Cholankeril G, Patel R, Khurana S, et al. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World J Hepatol. 2017;9(11):533–543.
- Wiggins T, Guidozzi N, Welbourn R, et al. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: a systematic review and Meta-analysis. PLoS Med. 2020;17(7):e1003206–18.
- Fakhry TK, Mhaskar R, Schwitalla T, et al. Bariatric surgery improves non-alcoholic fatty liver disease: a contemporary systematic review and Meta-analysis. Surg Obes Relat Dis. 2019;15(3):502–511.
- Agarwal L, Sahu AK, Baksi A, et al. Safety of metabolic and bariatric surgery in obese patients with liver cirrhosis: a systematic review and Meta-analysis. Surg Obes Relat Dis. 2021;17(3):525–537.
- Jirapinyo P, McCarty TR, Dolan RD, et al. Effect of endoscopic bariatric and metabolic therapies on nonalcoholic fatty liver disease: a systematic review and Meta-analysis. Clin Gastroenterol Hepatol [Internet]. 2022;20(3):511–524.e1.